Stay up-to-date on company announcements and industry news.

Medication-assisted treatment (MAT) is a proven, evidence-based approach to treating opioid use disorder, yet less than 12% of individuals who need it receive it.

Systemic barriers—including provider shortages, regulatory hurdles, and stigma—prevent widespread adoption, leaving millions without access to life-saving care. As the opioid crisis continues to devastate communities, expanding access to MAT is more urgent than ever.
‍

So, what’s standing in the way?
‍

Many healthcare organizations struggle with integrating MAT into existing care models, while reimbursement challenges and restrictive policies create additional roadblocks. Without intervention, these gaps in care will only widen, further impacting patient outcomes and healthcare costs.

Addressing these challenges requires a coordinated effort among policymakers, providers, and payers to remove barriers and expand treatment availability. In our latest white paper, we break down the key obstacles to MAT adoption and outline actionable solutions for healthcare leaders looking to drive change.

‍Download it now to explore how we can work together to close this critical gap and improve access to evidence-based addiction treatment.